MR tracking of iron-labeled glass radioembolization microspheres during transcatheter delivery to rabbit VX2 liver tumors: Feasibility study

Radiology

Volumn 249, Issue 3, 2008, Pages 845-854

  Gupta, Twinkle ^a   Virmani, Sumeet ^a   Neidt, Tod M ^a   Szolc Kowalska, Barbara ^a   Sato, Kent T ^a   Ryu, Robert K ^a   Lewandowski, Robert J ^a   Gates, Vanessa L ^a   Woloschak, Gayle E ^a   Salem, Riad ^a   Omary, Reed A ^a   Larson, Andrew C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; MICROSPHERE; DIAGNOSTIC AGENT; GLASS; YTTRIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ARTIFICIAL EMBOLISM; CATHETER; CONTROLLED STUDY; HEPATIC ARTERY; HISTOPATHOLOGY; IN VIVO STUDY; LIVER PARENCHYMA; LIVER TUMOR; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RABBIT; ANIMAL; CATHETERIZATION; EMBOLISM; FEASIBILITY STUDY; IMAGE QUALITY; PATHOLOGY;

ANIMALS; CATHETERIZATION; EMBOLISM; FEASIBILITY STUDIES; GLASS; IRON; LIVER NEOPLASMS, EXPERIMENTAL; MAGNETIC RESONANCE IMAGING; MICROSPHERES; PHANTOMS, IMAGING; RABBITS; YTTRIUM RADIOISOTOPES;

EID: 58149191791     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2491072027     Document Type: Article

References (20)

1. Salem R, Thurston KG, Carr BI, Goin JE, Ge- schwind JF. Yttrium-90 microspheres: radiation therapy for unresectable liver cancer. J Vasc Interv Radiol 2002;13(9 pt 2):S223-S229.
2. Salem R, Lewandowski RJ, Atassi B, et al. Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival. J Vasc Interv Radiol 2005;16:1627-1639.
3. Salem R, Thurston KG. Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. III. Comprehensive literature review and future direction. J Vasc Interv Radiol2006;17:1571-1593.
4. Salem R, Thurston KG. Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. II. Special topics. J Vasc IntervRadiol2006;17:1425-1439.
5. Salem R, Thurston KG. Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. I. Technical and meth- odologic considerations. J Vasc Interv Radiol 2006; 17:1251-1278.
6. Ackerman NB. Experimental studies on the circulation dynamics of intrahepatic tumor blood supply. Cancer 1972;29:435-439.
7. Nijsen JF, Seppenwoolde JH, Havenith T, Bos C, Bakker CJ, van het Schip AD. Liver tumors: MR imaging of radioactive holmium microspheres- phantom and rabbit study. Radiology 2004;231:491-499.
8. Seppenwoolde JH, Nijsen JF, Bartels LW, Ziel- huis SW, van Het Schip AD, Bakker CJ. Internal radiation therapy of liver tumors: qualitative and quantitative magnetic resonance imaging of the biodistribution of holmium-loaded microspheres in animal models. Magn Reson Med 2005;53:76-84.
9. Bulte JW, Douglas T, Witwer B, et al. Magneto-dendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol 2001;19:1141-1147.
10. Bulte JW, Duncan ID, Frank JA. In vivo magnetic resonance tracking of magnetically labeled cells after transplantation. J Cereb Blood Flow Metab 2002;22:899-907.
11. Geschwind JF, Artemov D, Abraham S, et al. Che-moembolization of liver tumor in a rabbit model: assessment of tumor cell death with diffusion-weighted MR imaging and histologic analysis. J Vasc Interv Radiol2000;11:1245-1255.
12. Murthy R, Nunez R, Szklaruk J, et al. Yttrium-90 microspheretherapyforhepaticmalignancy:devices, indications, technical considerations, and potential complications. RadioGraphics 2005;25(Spec Issue): S41-S55.
13. Yablonskiy DA, Haacke EM. An MRI method for measuring T2 in the presence of static and RF magnetic field inhomogeneities. Magn Reson Med 1997;37:872-876.
14. Smirnov P, Lavergne E, Gazeau F, et al. In vivo cellular imaging of lymphocyte trafficking by MRI: a tumor model approach to cell-based anticancer therapy. MagnResonMed2006;56:498-508.
15. Seppenwoolde JH, Viergever MA, Bakker CJ. Passive tracking exploiting local signal conservation: the white marker phenomenon. Magn Reson Med 2003;50:784-790.
16. Stuber M, Gilson WD, Schar M, et al. Positive contrast visualization of iron oxide-labeled stem cells using inversion-recovery with ON-resonant water suppression (IRON). Magn Reson Med 2007;58(5):1072-1077.
17. Haacke EM, Brown RW, Thompson MR, Venkate-san R. Magnetic resonance imaging: physical principles and sequence design. New York, NY: Wiley-Liss, 1999.
18. SchenckJF. The role of magnetic susceptibility in magnetic resonance imaging: MRI magnetic compatibility of the first and second kinds. Med Phys 1996;23:815-850.
19. KimHC,ChungJW,LeeW,JaeHJ,ParkJH.Recog-nizing extrahepatic collateral vessels that supply hepatocellular carcinoma to avoid complications of trans-catheter arterial chemoembolization. RadioGraphics 2005;25(Spec Issue):S25-S39.
20. Mansberg R, Sorensen N, Mansberg V, Van der Wall H. Yttrium 90 Bremsstrahlung SPECT/CT scan demonstrating areas of tracer/tumour uptake. Eur J Nucl Med MolImaging2007;34:1887.